Cargando…
Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
BACKGROUND: Cholangiocarcinoma (CCA), an epithelial malignancy of the biliary tree, is one of the aggressive cancers with poor prognosis and unsatisfactory response to chemotherapy with acquired resistance. NAD(P)H-quinone oxidoreductase 1 (NQO1), an antioxidant/detoxifying enzyme, plays important r...
Autores principales: | Srijiwangsa, Pimradasiri, Ponnikorn, Saranyoo, Na-Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006851/ https://www.ncbi.nlm.nih.gov/pubmed/29914576 http://dx.doi.org/10.1186/s40360-018-0223-4 |
Ejemplares similares
-
The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2021) -
β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
por: Narahara, Chisato, et al.
Publicado: (2020) -
β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation
por: Acharya, Bishwanath, et al.
Publicado: (2022) -
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023) -
Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2020)